Pere Barba, MD^1*, Mi Kwon, MD, PhD^2*, Javier Briones, MD, PhD^3*, Ulrich Jaeger, MD⁴, Emmanuel Bachy, MD, PhD^5*, Didier Blaise, MD, PhD⁶, Nicolas Boissel, MD, PhD⁷, Koji Kato, MD, PhD^8*, Nirav N. Shah, MD⁹, Matthew Frigault, MD, MS¹⁰, Peter A. Riedell, MD^11*, Leyla O. Shune, MD¹², Takanori Teshima, M.D., Ph.D.¹³, Fabio Ciceri, MD^14*, David Pearson, PhD^15*, Elena J Orlando, PhD^16*, Lan Yi, PhD^17*, Jaclyn Davis, MD¹⁸, Aisha Masood, MD¹⁷, Ian W. Flinn, MD PhD¹⁹ and Michael Dickinson, MD²⁰

¹Hematology Department, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
²Department of Hematology, Institute of Health Research Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
³Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
⁴Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Vienna General Hospital – Medical University of Vienna, Vienna, Austria
⁵Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
⁶Département d'hématologie, Programme de transplantation et de thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille University, Institut Paoli Calmettes, Marseille, France
⁷Hematology Adolescent and Young Adult Unit, France, Paris Cedex 10, France
⁸Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
⁹Medical College of Wisconsin, Milwaukee, WI
¹⁰Massachusetts General Hospital, Dorchester, MA
¹¹Department of Medicine, The University of Chicago, Chicago, IL
¹²The University of Kansas Medical Center, Kansas City, KS
¹³Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
¹⁴Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
¹⁵Novartis Institutes for BioMedical Research, Basel, MA, Switzerland
¹⁶Novartis Institutes for BioMedical Research, Cambridge, MA
¹⁷Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁸Novartis Institutes for BioMedical Research, East Hanover, NJ
¹⁹Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
²⁰Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia

Caron A. Jacobson, MD¹, Caroline Falvey^1*, Riemke Bouvier^1*, Sarah Hogan^1*, Elizabeth Kendricken, BSN, RN^1*, Julia Jones^1*, Elizabeth Grimm^1*, Robert A. Redd, MS^2*, Eudocia Q Lee^1*, Luis Gonzalez Castro^1*, Ugonma Chukwueke^1*, Jose McFaline Figueroa^1*, Austin I. Kim, MD³, Alexandra Torres^1*, Linda Ramsdell^1*, Leslie S. Kean, MD, PhD⁴, Ulrike Gerdemann, MD⁵, Alexandre Albanese^6*, Paula Keskula^5*, David Meredith^7*, Lynette Sholl^7*, Soumya Poddar, PhD^8*, Madison Davis^9*, Daquin Mao^9*, Simone Filosto, PhD^8*, Mike Mattie, PhD^8*, Philippe Armand, MD PhD¹⁰ and Lakshmi Nayak, MD¹¹

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
⁴Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA
⁵Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
⁶Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁷Brigham and Women's Hospital, Boston, MA
⁸Kite, a Gilead Company, Santa Monica, CA
⁹Kite Pharma, Santa Monica, CA
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹¹Dana Farber Cancer Institute, Boston, MA

Martin Hutchings, MD, PhD^1*, Carmelo Carlo-Stella, MD, PhD², Franck Morschhauser, MD, PhD^3*, Emmanuel Bachy, MD, PhD^4*, Paolo Corradini, MD⁵, Gloria Iacoboni, MD^6*, Cyrus Khan^7*, Krish Patel^8*, Mark Hertzberg, MBBS^9*, Lorenzo Falchi, MD¹⁰, Nancy L. Bartlett, MD¹¹, Joshua Brody, MD¹², Linda Lundberg^13*, Yuying Xie^14*, Estefania Mulvihill^13*, Pauline Baumlin^13*, James Relf^15*, Emily Piccione^16*, Kathryn Humphrey^15* and Michael Dickinson, MD¹⁷

¹Rigshospitalet, Copenhagen, Denmark
²Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
³Hematology Department, Lille University Hospital, Lille, France
⁴Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
⁵Università degli Studi di Milano and Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCSS) Istituto Nazionale dei Tumori, Milan, Italy
⁶Vall d’Hebron University Hospital, Barcelona, Spain
⁷Allegheny Health Network, Pittsburgh, PA
⁸Swedish Cancer Institute, Seattle, WA
⁹Prince of Wales Hospital and University of New South Wales, Sydney, NSW, Australia
¹⁰Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹²Tisch Cancer Institute, New York, NY
¹³F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁴F. Hoffmann-La Roche Ltd, Mississauga, Canada
¹⁵Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁶Genentech, Inc., South San Francisco, CA
¹⁷Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia

Alex F. Herrera, MD¹, Lu Chen, PhD^2*, Jennifer L. Crombie, MD^3*, Jonathon B. Cohen, MD, MS⁴, Ranjana H. Advani, MD⁵, Ann S. LaCasce, MD⁶, Leslie L. Popplewell, MD, FACP, MPH⁷, Sandrine Puverel, PhD^1*, Lacolle Peters^8*, Shari Daniels^1*, James Godfrey, MD⁹, Geoffrey Shouse, PhD, DO¹⁰, Matthew Mei, MD¹¹, Swetha Kambhampati, MD¹², Elizabeth L. Budde, MD, PhD¹³, Liana Nikolaenko, MD¹¹, Steven T. Rosen, MD¹⁴, Larry W. Kwak, MD, PhD¹⁵, Stephen J Forman, MD¹⁰ and Matthew J. Matasar, MD, MS¹⁶

¹City of Hope, Duarte, CA
²Department of Information Sciences, City of Hope, Duarte
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
⁵Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
⁶Division of Hematologic Malignancies, Dana-Farber Cancer Inst., Boston, MA
⁷Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁸City of Hope National Medical Center, Duarte, CA
⁹City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁰Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
¹¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹²City of Hope National Medical Center, DUARTE, CA
¹³Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹⁴Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
¹⁵Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁶215 West 90th St, 14E, Memorial Sloan Kettering Cancer Center, New York, NY

Pau Abrisqueta, MD, PhD^1*, Raul Cordoba, MD, PhD², Lorenzo Falchi, MD³, Sven de Vos, MD, PhD⁴, Marcel Nijland, MD, PhD^5*, Fritz Offner, MD, PhD⁶, Jun Wu, MD, MS^7*, Irina Bykhovski, PharmD^8*, Liwei Wang, PhD^8*, Ali Rana, MD, PhD^8* and Tycel Phillips, MD^9*

¹Hospital Universitari Vall d’Hebron, Barcelona, Spain
²Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
³Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, CA
⁵Department of Hematology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands
⁶Universitair Ziekenhuis Gent, Ghent, Belgium
⁷AbbVie, North Chicago, IL
⁸Genmab, Princeton, NJ
⁹University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

Won-Seog Kim, MD, PhD^1*, Tae Min Kim, MD, PhD^2*, Seok-Goo Cho, M.D., Ph.D.^3*, Isidro Jarque, MD^4*, Elżbieta Iskierka-Jażdżewska, MD^5*, Michelle Limei Poon, MBBS, MRCP^6*, H. Miles Prince, MD, FRACP, FRCPA⁷, Sung Yong Oh, MD^8*, Francesca Lim, MD^9*, Cecilia Carpio, MD^10*, Tran-Der Tan, MD¹¹, Sabarish Ayyappan, MD^12*, Antonio Gutierrez, MD, PhD^13*, Jingjin Li, PhD^14*, Melanie Ufkin, PhD¹⁴, Min Zhu, PhD^14*, Aafia Chaudhry, MD, MBA, MS^14*, Hesham Mohamed, MD^14*, Srikanth R. Ambati, MBBS, MD^14* and Jan Walewski, MD, PhD¹⁵

¹Samsung Medical Center, Center for Hematologic Malignancy, Seoul, Korea, Republic of (South)
²Seoul National University Hospital, Seoul, Korea, Republic of (South)
³The Catholic University of Korea, Seoul St. Mary's Hospital Hematology, Seoul, Korea, Republic of (South)
⁴Hospital Universitari i Politecnic La Fe, Valencia, Spain
⁵H Copernicus Memorial Hospital, Department of Hematology, Medical University of Łódź, Łódź, Poland
⁶Hematology Oncology National University Hospital, Singapore, Singapore
⁷Epworth Healthcare and University of Melbourne, East Melbourne, Australia
⁸Dong-A University Hospital, Busan, Korea, Republic of (South)
⁹Singapore General Hospital, Singapore, Singapore
¹⁰Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Autonomous University of Barcelona (UAB), Barcelona, Spain
¹¹Hematology and Medical Oncology Koo Foundation Sun Yat Sen Cancer Center, Taipei City, Taiwan
¹²University of Iowa Hospital and Clinics, Iowa City, IA
¹³Hospital Universitari Son Espases, Palma, Spain
¹⁴Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹⁵Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland